CHRW
C.H. Robinson Worldwide, Inc.
CHRW has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CHRW overall, supported by stronger valuation and stronger fundamentals.
CHRW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Stable |
CHRW's revenue and profitability are currently healthy, and its balance sheet is stable, but its cash flow is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CHRW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $85.25 | -37% |
| Forward | 18x | $134 | — |
| Fair | 24x | $132 | -1.6% |
| Current | 24x | $134 | — |
| Expensive | 34x | $188 | +40% |
Historical ranges are pointers, not guarantees.
CHRW's PE is in its fair range at 24x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CHRW in the historical PE scenario, which offers more potential upside but is not a forecast.
CHRW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CHRW, with profitability holding steady.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over CHRW on the outlook, with more favorable profitability expectations.
CHRW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.30 | +31% |
| Q3 2026 | $5.57 | +13% |
| Q2 2026 | $5.24 | +19% |
| Q1 2026 | $4.94 | +18% |
| Q4 2025 | $4.83 | +25% |
| Q3 2025 | $4.94 | +70% |
| Q2 2025 | $4.40 | +58% |
| Q1 2025 | $4.19 | +65% |
| Q4 2024 | $3.86 | +42% |
CHRW's earnings per share have fallen from their peak: $5.57 over the past year, against $8.31 in mid-2022.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CHRW on earnings, with stronger typical year-over-year growth.
CHRW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.4B | +30% |
| Q2 2026 | $4.9B | +19% |
| Q1 2026 | $4B | -0.8% |
| Q4 2025 | $3.9B | -6.5% |
| Q3 2025 | $4.1B | -11% |
| Q2 2025 | $4.1B | -7.7% |
| Q1 2025 | $4B | -8.3% |
| Q4 2024 | $4.2B | -0.9% |
CHRW's revenue is recovering but still below its 2022 peak: $5.4B last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | -0.3 points |
| Q2 2026 | 5.2% | 0 points |
| Q1 2026 | 4.4% | 0 points |
| Q4 2025 | 4.6% | +0.3 points |
| Q3 2025 | 5.3% | +1.5 points |
| Q2 2025 | 5.2% | +1.2 points |
| Q1 2025 | 4.4% | +1.5 points |
| Q4 2024 | 4.4% | +1.8 points |
CHRW's operating margin was 5.1% last quarter, about level with the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CHRW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CHRW on profitability, with a higher operating margin.
CHRW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $120.5M | -55% |
| Q2 2026 | $30.9M | -86% |
| Q1 2026 | $66M | -36% |
| Q4 2025 | $302.4M | +14% |
| Q3 2025 | $269.5M | +161% |
| Q2 2025 | $219.8M | +38% |
| Q1 2025 | $103.2M | +$145.1M |
| Q4 2024 | $265.3M | +514% |
CHRW still generates free cash flow, though less than at its 2022 peak: $520M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over CHRW on cash flow, with more consistent year-over-year improvement.
CHRW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -1M shares |
| 1 year | -2.2% | -2.6M shares |
| 3 years | -0.9% | -1M shares |
| 5 years | -11% | -14.7M shares |
| Available history | -13% | -17.9M shares |
CHRW has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $207.7M |
| Q2 2026 | $219.5M |
| Q1 2026 | $212.7M |
| Q4 2025 | $114.4M |
| Q3 2025 | $111.5M |
| Q2 2025 | $81.1M |
| Q1 2025 | $47.7M |
| Q4 2024 | — |
CHRW spent $754M buying back its own shares over the past year, about three times what it spent the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CHRW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 1.0x | Healthy |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.6x | Healthy |
CHRW's net debt is about 1.7 years of its operating earnings (EBITDA), up from 1.2 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CHRW on leverage, with a lower net debt burden relative to earnings.
CHRW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.0 | Neutral |
| Stochastic | 15.4 | Oversold |
CHRW's weekly RSI is 41 (neutral) and its Stochastic is 15 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CHRW PE vs Industrials Sector
| Metric | CHRW | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 0.2% above |
| PE % | 51 | 58 | 7 pts below |
CHRW has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CHRW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $139.0 | 3.3% below |
| 20 week MA | $154.1 | 13% below |
| 50 week MA | $166.9 | 19% below |
| 100 week MA | $139.0 | 3.3% below |
| 200 week MA | $115.3 | 17% above |
CHRW has fallen below most of its moving averages, though it's still 17% above its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over CHRW on trend strength, trading above more of its moving averages.
CHRW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.9 | $94.7 | +21% |
| 2021 | $94.7 | $102.5 | +8.2% |
| 2022 | $102.5 | $93.1 | -9.1% |
| 2023 | $93.1 | $86.4 | -7.2% |
| 2024 | $86.4 | $103.9 | +20% |
| 2025 | $103.9 | $164.6 | +58% |
| 2026 YTD | $164.6 | $134.4 | -18% |
CHRW has finished higher in four of the last six years. It's down 18% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CHRW on returns for 2026, with the stronger performance.